Amylyx Pharmaceuticals
Amylyx Pharmaceuticals is seeking an R&D Operations Manager to lead operational planning and execution for the preclinical research and development organization. This role acts as a key business partner to scientific leadership, overseeing toxicology, bioanalytical, and translational research activities through vendor management, financial planning, and process optimization.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
8% below the average for this role
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Associate Director, Study Toxicologist
Madrigal Pharmaceuticals
Head of Translational Biology
Earli, Inc.
Distinguished Scientist, Head of Investigative Toxicology US
Sanofi
Executive Director, Head of Toxicology
Centessa Pharmaceuticals
Scientific Director | tRNA Biotherapeutics
Jobgether
Translational Lead
Tonix Pharmaceuticals